<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04234893</url>
  </required_header>
  <id_info>
    <org_study_id>BEYOND Registry</org_study_id>
    <nct_id>NCT04234893</nct_id>
  </id_info>
  <brief_title>Bingo Drug-Coated Balloon in Real World</brief_title>
  <official_title>A Registry Study of Bingo Drug-Coated Balloon in Real World</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yinyi(Liaoning) Biotech Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yinyi(Liaoning) Biotech Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to observe and evaluate the safety and efficacy of Bingo drug-coated balloon
      in the real world.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>12 months</time_frame>
    <description>a composite endpoint of cardiovascular death, myocardial infarction, clinical driven target lesion revascularization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>device success</measure>
    <time_frame>immediately after the procedure</time_frame>
    <description>study device successfully dilate in the lesion without using bail-out stent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lesion success</measure>
    <time_frame>immediately after the procedure</time_frame>
    <description>residual diameter stenosis ≤30% and the TIMI flow grade 3 of the target lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical success</measure>
    <time_frame>immediately after the procedure， up to 7 days</time_frame>
    <description>lesion success without in-hospital MACE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of Target lesion revascularization</measure>
    <time_frame>1, 6, 12 and 24 months</time_frame>
    <description>repeat percutaneous intervention of the target lesion or bypass surgery of the target vessel performed for restenosis or other complication of the target lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>1, 6, 12 and 24 months</time_frame>
    <description>a composite endpoint of cardiovascular death, target vessel myocardial infarction, clinical driven target lesion revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute vessel closure</measure>
    <time_frame>during the procedure and up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion thrombosis</measure>
    <time_frame>immediately after the procedure， up to 24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Coronary Stenosis</condition>
  <condition>Drug-coated Balloon</condition>
  <condition>De Novo Stenosis</condition>
  <condition>Coronary Artery Disease in Transplanted Heart Accelerated</condition>
  <arm_group>
    <arm_group_label>Drug-coated balloon</arm_group_label>
    <description>The Patients who treated with Bingo drug-coated balloon</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        PCI with Bingo drug-coated balloon
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 or older, regardless of gender;

          2. Patients suitable for PCI with paclitaxel drug-coated balloon;

          3. Patients able to understand the purpose of this study, provide an informed consent and
             cooperate with clinical follow-up.

        Exclusion Criteria:

        General exclusion criteria

          1. Contraindications to PCI;

          2. In-stent restenosis;

          3. Life expectation less than 1 year;

          4. Patients not suitable for enrollment considered by investigator.

        Angiographic exclusion criteria:

        1. Target lesion with the following conditions after pre-dilatation:

          1. Residual stenosis larger than 30% ;

          2. TIMI flow grade less than 3;

          3. Type C-F dissection (NHLBI grade).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jian-an Wang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jian-an Wang, MD, PhD</last_name>
    <phone>+86-13805786328</phone>
    <email>wang_jian_an@tom.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jun Jiang, MD, PhD</last_name>
    <phone>+86-13588706891</phone>
    <email>drjayj@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Second Affiliated hospital of Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jian-an Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jun Jiang, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>January 15, 2020</last_update_submitted>
  <last_update_submitted_qc>January 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Stenosis</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Drug-coated Balloon</keyword>
  <keyword>Drug eluting Balloon</keyword>
  <keyword>Paclitaxel</keyword>
  <keyword>De novo</keyword>
  <keyword>Bifurcation</keyword>
  <keyword>Coronary Artery Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

